Haematological malignancies in pregnancy: time for accurate incidence data

Affiliations

¹ Department of Clinical Haematology, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France. Electronic address: rudy.birsen@aphp.fr.
² Clinical Research Unit, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France.
³ Department of Perinatal, Pediatric and Adult Pharmacology, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France.
⁴ Department of Biological Haematology, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France.
⁵ Department of Perinatal, Pediatric and Adult Pharmacology, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France; Clinical Research Unit, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France.

Comment

Rudy Birsen et al. Lancet Haematol. 2023 Sep.

. 2023 Sep;10(9):e705.

doi: 10.1016/S2352-3026(23)00238-7.

¹ Department of Clinical Haematology, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France. Electronic address: rudy.birsen@aphp.fr.
² Clinical Research Unit, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France.
³ Department of Perinatal, Pediatric and Adult Pharmacology, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France.
⁴ Department of Biological Haematology, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France.
⁵ Department of Perinatal, Pediatric and Adult Pharmacology, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France; Clinical Research Unit, Cochin Hospital, AP-HP, University Paris Cité, Paris 75014, France.

No abstract available

Conflict of interest statement

We declare no competing interests.

Haematological malignancies in pregnancy: time for accurate incidence data - Authors' reply.
Mills GS. Mills GS. Lancet Haematol. 2023 Sep;10(9):e705-e706. doi: 10.1016/S2352-3026(23)00241-7. Lancet Haematol. 2023. PMID: 37652596 No abstract available.

Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility.
Mills GS, Chadwick V, Tang C, Perram J, Anderson MA, Anazodo A, Kidson-Gerber G, Shand A, Lavee O, Withers B, Milliken S, Di Ciaccio PR, Hamad N. Mills GS, et al. Lancet Haematol. 2023 Jun;10(6):e458-e467. doi: 10.1016/S2352-3026(23)00059-5. Lancet Haematol. 2023. PMID: 37263722